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Dogs are the source of more than 99% of human rabies virus infections in endemic regions. Without post-
exposure prophylaxis, almost all cases are fatal, making rabies the most lethal infectious disease. Tens of
thousands of deaths are reported annually, but the ofﬁcial ﬁgures are believed to be gross underesti-
mates. Controlling canine rabies, especially in free-ranging dogs, is the ﬁrst priority to reduce the burden
of human disease. Because of their limited medical infrastructure, most endemic countries lack the lab-
oratory facilities needed to diagnose human cases of viral encephalitis. Moreover, the veterinary sectors
are often unable to undertake systematic surveillance and reporting of rabies in animals. Without an ade-
quate and functioning risk assessment system that is primed for use, rabies will remain a ‘neglected’ and
omnipresent disease, especially in poverty-stricken regions of the world. Fortunately, experience with the
elimination of canine rabies from many industrialized countries has shown that these barriers are not
insurmountable. Successful rabies prevention and control strategies that prove the absence of the disease
depend on laboratory-based surveillance, rapid data reporting and an adequate system of risk assess-
ment. Future control and prevention programmes should therefore coordinate the development of these
key factors, creating synergies to eliminate rabies at its animal source. This article forms part of a sym-
posium in Antiviral Research on the global elimination of canine rabies.
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Rabies is a neglected zoonotic disease that causes severe and
long-lasting societal and economic burdens. Its implications are
especially apparent in poverty-stricken less-developed countries,
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world’s population, being endemic across most of Africa and Asia
(Fooks, 2005; Hampson et al., 2008). Rabies is generally considered
to be a fast-moving transboundary disease that does not respect
borders and is the most important human zoonosis causing tens
of thousands of deaths per year, mostly in children (Rupprecht
et al., 2008; WHO, 2005).
The case fatality rate of human rabies is the highest of all infec-
tious diseases; once clinical disease develops, the resulting illness
is almost uniformly lethal. Insufﬁcient ﬁnancial resources, a weak
health care infrastructure and inadequate reporting systems all
contribute to under-reporting of the disease. In addition, more rig-
orous public disclosure is urgently needed to determine the true
global burden of rabies (Fooks, 2005; Knobel et al., 2007). This lack
of empirical data has been a principal cause of the low prioritiza-
tion of rabies control in endemic countries (Rupprecht et al., 2008).
In this article, we review obstacles to the elimination of canine
rabies in resource-limited countries, and establish the critical role
of validated diagnostic tests and surveillance systems in the man-
agement of rabies. Our paper forms part of a symposium in Antivi-
ral Research on the global elimination of canine rabies. Other
articles published to date provide a general overview of the prob-
lem (Meslin and Briggs, 2013), describe the potential economic
beneﬁts of eliminating the disease (Shwiff et al., 2013) and the role
of public-private partnerships in rabies control efforts (Taylor,
2013).2. Rabies: virus and disease
Rabies is caused by viruses in the genus Lyssavirus in the family
Rhabdoviridae, order Mononegavirales (Dietzgen et al., 2011; Freul-
ing et al., 2011; Marston et al., 2012). Each of the 12 recognized lys-
savirus species has its own distinct geographic and host range
distribution. Only the prototype species, rabies virus, is detected
in domestic and wild animals worldwide.
Canine rabies has been eliminated from many regions through
veterinary service initiatives, including the mandatory registration
and vaccination of dogs and requirements for responsible dog
ownership (Blanton et al., 2012; CDC, 2007). Oral vaccination cam-
paigns for wildlife have also removed the threat of sylvatic rabies
from carnivores in some areas (Muller et al., 2012). However, de-
spite successes in Western Europe and parts of North America
(MacInnes et al., 2001; Müller et al., 2012), rabies virus continues
to circulate in independent epidemiological cycles in wild carni-
vores in other regions. Lyssavirus species and other zoonotic
pathogens in bats continue to emerge as a public health threat
(Banyard et al., 2011; Cutler et al., 2010; Gilbert et al., 2012).3. The burden of rabies in Asia
The human rabies burden is highest in Asia, with most deaths
occurring in India (Burki, 2008). This situation reﬂects the relative
lack of systematic control and prevention initiatives, including sur-
veillance and response systems. However, even though rabies is a
major public health problem in India, it is only one of many infec-
tious diseases threatening humans: cholera, viral hepatitis, lepto-
spirosis, anthrax, tuberculosis, malaria and HIV infections also
impose a heavy burden. Because vaccine-preventable diseases,
especially in children, are the ﬁrst public health priority (John
et al., 2011), rabies and other zoonoses tend to be neglected, as
they are not seen as the responsibility of either human or veteri-
nary health care providers.
The most recent attempt to quantify the burden of human ra-
bies in India concluded that its incidence was 2 per 100,000 popu-
lation, giving an annual total of more than 20,000 deaths (Burki,2008; Sudarshan, 2007). The key priorities in the ﬁght against ra-
bies are enhanced laboratory capabilities, improved access to mod-
ern vaccines, enforcement of responsible dog ownership, and
enhanced public education and awareness of the disease. With
an emerging global economy, India clearly must implement mech-
anisms to reduce and eliminate rabies. The ﬁrst step will be the
establishment of an ofﬁcial OIE reference laboratory in the Indian
subcontinent region. The successful partnership between the exist-
ingWHO collaborating center for rabies in India (Bangalore) and an
OIE reference laboratory would enhance surveillance activity and
reporting of rabies cases in humans and animals to international
organisations.
The populations of other Asian countries suffer from a similar
rabies burden and as in India dogs are the principal reservoir. In
China, for example, the number of human infections has increased
exponentially over the last 15 years, attributed to an under resour-
ced veterinary infrastructure, lack of knowledge of transmission
dynamics, inefﬁcient dog control and poor vaccination coverage
(Hu et al., 2009). Of the estimated 130 million dogs in China, more
than half are in rural areas; as a result, human rabies is a major
public health problem (Montgomery et al., 2012). Recent studies
of canine rabies dynamics in China have estimated a basic repro-
duction number (R0) of 2, and predicted that, even though human
cases are now decreasing, they will rise again before 2030 if mea-
sures are not taken to reduce the dog population and increase vac-
cination coverage (Zhang et al., 2011). In neighboring Nepal, a
coordinated approach has been taken with veterinary laboratories
positioned in key areas across the country (Fig. 1). Virus isolates
genetically typed from Nepal illustrate how the regular movement
of disease across land borders precludes implementation of efﬁ-
cient control and prevention strategies. Interestingly, a comparison
of reported cases with active surveillance and models of rabies
incidence based on dog bites suggest that the true incidence of ra-
bies may be 100 times what is reported to authorities (Knobel
et al., 2005; Pant et al., 2011). As well as being problematic to
the local population, the threat of rabies has been identiﬁed as a
key environmental hazard for travelers to the area (Boggild et al.,
2007; Pandey et al., 2002). At least in Nepal, the veterinary services
are in a position, with the necessary support, to establish a surveil-
lance network using existing facilities (Fig. 1).
To reduce rabies in humans, authorities should make the con-
trol and prevention of canine rabies a public health priority (Meslin
and Briggs, 2013). The overall national strategy should include im-
proved animal surveillance through laboratory diagnosis, a more
rapid response to human exposures (with provision of post expo-
sure prophylaxis, PEP) and education of the public and health care
providers (Montgomery et al., 2012; Meslin and Briggs, 2013). The
supply and quality of human rabies vaccines have also been a prob-
lem in China; the use of counterfeit vaccines has caused fatalities
and reduced the population’s willingness to be vaccinated (Hu
et al., 2008).
The rabies situation in Cambodia is especially tragic. Because
access to PEP is rare, patients are usually not hospitalized following
dog bites, and die in their homes (Ly et al., 2009). In 2007, the esti-
mated number of deaths from rabies exceeded those from malaria
and dengue. The Pasteur Institute in Phnom Penh is the only diag-
nostic laboratory in the country capable of providing free PEP and
undertaking postmortem diagnosis in humans. As in so many areas
where canine rabies is enzootic, a national system of diagnostic
evaluation and reporting is required, together with surveillance
initiatives to measure the true impact of the disease (Dodet
et al., 2008; Ly et al., 2009).
Many island nations have succeeded in eliminating rabies, but
some still struggle with the disease. This is most evident where
deﬁciencies in the veterinary sector preclude coordinated control
and prevention efforts. One such area is the Philippines, where ra-
Fig. 1. Laboratory network for rabies surveillance in Nepal. Five regional laboratories are responsible for testing samples within their speciﬁc region. They support a National
Reference Laboratory in Kathmandu, which undertakes conﬁrmatory diagnostic testing and further characterization of positive samples. Due to the frequent movement of
rabies across land borders, samples are also tested from animals that have been transported from neighbouring countries. Canine rabies control strategies would be more
feasible if samples from Nepal were systematically analyzed to conﬁrm the viral clades in circulation, which would assist in the overall goal of eliminating canine rabies in
Southeast Asia.
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2001). A recent retrospective study in Manila highlighted the difﬁ-
culty of assessing suspected rabies patients in a resource-limited
setting, and concluded that the true disease burden may be 10-
50% higher than reported (Dimaano et al., 2011). Together with
Tanzania and Kwa-Zulu Natal in South Africa, the Philippines has
been targeted for new initiatives by the Global Alliance for Rabies
Control and the Bill and Melinda Gates Foundation, which aim to
demonstrate the feasibility of eliminating canine rabies in a re-
source-limited setting (Anonymous, 2008; Alliance for Rabies Con-
trol, 2012; WHO, 2010, 2013).
Although networks of rabies experts exist in Asia, their re-
sources are limited; input from regional and national public health
authorities will be required to increase their impact. The Asian Ra-
bies Expert Bureau (AREB), founded in 2004, is an informal net-
work of experts from 12 countries, which aims to eliminate
human rabies deaths from Asia. Using the goals of the AREB as a
framework, and with guidance from the WHO, several Asian coun-
tries have resolved to eliminate human rabies by 2020. Achieving
this goal will require raising awareness, educating the public and
new reporting and surveillance initiatives.
To support country-based initiatives aimed at increased rabies
awareness, the AREB recently surveyed some 4000 animal bite vic-
tims from eight countries, and found that the situation of such pa-
tients could be markedly improved through education on
appropriate wound care and timely consultation with a rabies pre-
vention center (Dodet et al., 2008) However, the nearest primary
health centre is often prohibitively distant, and its medical staff
are unlikely to have access to a diagnostic laboratory or be able
to provide PEP. Additional resources are clearly required (Estrada
et al., 2001; Matibag et al., 2009).
A similar network, the Middle East and Eastern Europe Rabies
Expert Bureau (MEEREB) network that was established in 2010,
has improved regional collaboration (Aylan et al., 2011). Surveil-
lance and reporting of rabies in the Middle East is variable, withmany Middle East countries collating and reporting human rabies
cases, but few reporting animal rabies (Aylan et al., 2011; Seimenis,
2008). Iraq is one example where there is a national system for
reporting human rabies (albeit based on clinical diagnosis) but
no systematic approach for animal rabies surveillance (Horton
et al., 2013).4. The burden of rabies in Africa
The true impact of rabies in Africa remains undeﬁned. Although
the number of countries reporting laboratory-conﬁrmed cases of
human rabies has decreased over the past 10 years (WHO, 2010),
studies predicting the true number of human cases using indirect
measures demonstrate that in Africa rabies is also under-reported
because of poor surveillance and reporting structures (Fooks, 2005;
Knobel et al., 2005). The virus is sporadically detected in wildlife,
but canine rabies poses the greatest threat to humans. An im-
proved understanding of dog ecology in Africa is therefore essen-
tial to the success of rabies control and prevention through
vaccination campaigns (Kayali et al., 2003; Lembo et al., 2010; Per-
ry and Wandeler, 1993; Wandeler et al., 1993). Region-speciﬁc
studies, such as those in Tanzania, have improved rabies surveil-
lance and control (Beyer et al., 2011; Cleaveland et al., 2010). A re-
cent study in Uganda has also emphasized the need for active
surveillance of animal bites and improved data on canine rabies,
to improve mortality estimates and determine the true disease
burden (Fevre et al., 2005).
Fortunately, recent initiatives have begun to improve the situa-
tion in many areas with the Southern and East African Rabies
Group (SEARG), the African Rabies Expert Bureau (AfroREB) and
the Rabies in West Africa (RIWA) group being networks dedicated
to the ﬁght against rabies. A recent AfroREB report stated that reli-
able data on the burden of rabies are still needed for informed deci-
sion-making and to set priorities. Unfortunately, rabies is
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facilities for laboratory conﬁrmation. It is important to make rabies
a notiﬁable disease in such countries (Anonymous, 2008). One fu-
ture objective is collaboration between these African networks to
create a pan-African approach to improve surveillance and report-
ing strategies.5. Obstacles to rabies control and prevention
Controlling and preventing rabies in dogs is crucial to prevent-
ing the disease in humans (Coleman and Dye, 1996). Showcase ini-
tiatives have demonstrated that the elimination of canine rabies
from Africa and Asia is epidemiologically and practically feasible,
through mass vaccination and enforcement of responsible dog
ownership (Durr et al., 2009; Kaare et al., 2009; Zinsstag et al.,
2009). However, even though the tools are available, a number of
obstacles prevent a coordinated approach to the global elimination
of canine rabies, including: a lack of awareness and education of
the public health and veterinary sectors; the absence of diagnostic
facilities; inadequate surveillance and reporting systems; limited
access to modern vaccines; and failures of responsible dog owner-
ship (Sudarshan, 2007; Burki, 2008; Dodet et al., 2008; Zhang et al.,
2011). The lack of effective control of canine rabies in developing
countries is often attributed to low prioritization, epidemiological
and operational constraints and insufﬁcient ﬁnancial resources.
Because effective rabies control and prevention programmes re-
quire reliable information on disease occurrence, they should be
guided by modern epidemiological insights and driven by labora-
tory-based surveillance (Rupprecht et al., 2006a). Improved local
diagnostic capacity is essential to achieve adequate canine vaccina-
tion coverage and to assess the impact of control and elimination
efforts (Lembo et al., 2010). Since these factors are interlinked,
the implementation of one will positively enhance the others.
In addition to mechanisms to reduce rabies in domestic dogs,
the availability of simple and affordable diagnostics will enhance
reporting and identify areas where the disease is most burden-
some. In many countries, rabies diagnosis still relies on clinical
observations. In Bangladesh, for example, the true disease burden
cannot be accurately determined, because human cases are re-
ported without conﬁrmatory laboratory tests, and surveillance sys-
tems are not available. As in other endemic countries, the ﬁrst
priority for the development of a national rabies control program
is the establishment of a diagnostic laboratory infrastructure
(Hossain et al., 2011, 2012). As technical advances make diagnosis
more rapid, accurate and cost-effective, it will become easier to ini-
tiate such programs in resource-limited settings (Rupprecht et al.,
2006a).6. Rabies control and prevention requires rapid and accurate
laboratory-based diagnosis
Before discussing recommendations for rabies surveillance and
diagnosis, we should provide some deﬁnitions. The OIE deﬁnes sur-
veillance as the systematic ongoing collection, collation, and analy-
sis of information related to animal health, and the timely
dissemination of that information to those who need to know, so
that action can be taken (OIE, 2012). A case of rabies is deﬁned as
any animal infected with rabies virus, as determined by the tests
prescribed in the Terrestrial Animal Health Code (OIE, 2012). Sus-
pect and probable cases of rabies in animals are usually deﬁned
at the national level. In the context of this review, diagnosis refers
to the clinical and laboratory information that lead to conﬁrmation
of a case of rabies.
The lack of laboratory capacity in endemic areas means that ra-
bies is usually diagnosed clinically, but because the disease has nopathognomonic signs and its manifestations are highly variable,
this approach is often inaccurate. For example, a study in Malawi
found that three of 26 patients diagnosed with cerebral malaria
actually had rabies (Mallewa et al., 2007). The differential diagno-
sis of all cases of encephalitis in rabies-endemic countries should
therefore include rabies (Fooks et al., 2009).
Rabies can, however, be diagnosed clinically when an animal
bite is followed by a compatible neurological illness. It is difﬁcult
to accurately assess the rabies status of dog populations without
sufﬁcient testing of suspect dogs. The diagnosis should also be con-
sidered when a patient without a history of a bite develops an
acute, unexplained neurological disease, especially if it progresses
rapidly to coma and death (Rupprecht, 2006). Globally, hundreds of
thousands of persons are potentially exposed to rabies each year,
and most require some form of PEP. The inability to perform diag-
nostic evaluations of suspect animals thus results in inappropriate
estimates of the level of vaccination required and major ﬁnancial
costs (Shwiff et al., 2013). From 20 to 40,000 people in the US
may receive PEP each year (Christian et al., 2009), but post expo-
sure care is scarce in resource-limited settings. In Tanzania, for
example, where human rabies cases are greatly under-reported,
the number of dog bites can be used to estimate the disease burden
and monitor epidemiological trends (Cleaveland et al., 2002).
Even when local facilities and infrastructure make diagnostic
testing possible, the cost of even the simplest tests places a further
burden on the health system. Rabies diagnosis often requires costly
and time-consuming procedures, such as the OIE-prescribed ﬂuo-
rescent antibody test (FAT), with the potential for a conﬁrmatory
diagnosis by virus isolation (Table 1). Although it is rapid, sensitive
and speciﬁc, the FAT relies on expensive FITC-labeled anti-rabies
antibodies and a ﬂuorescence microscope, often precluding its
use in resource-limited settings. Virus isolation in tissue culture
also requires laboratory capabilities that are usually unavailable
where they are most needed. Fortunately, the direct, rapid immu-
nohistochemical test (dRIT) for rabies now provides a more eco-
nomical alternative to the FAT (Lembo et al., 2006). Simpler and
less expensive diagnostic platforms are needed to enhance labora-
tory capacity in rabies-endemic regions (Fooks et al., 2009).7. The need for improved surveillance
Experience from regions where rabies has been eliminated
shows that evidence-based diagnostic and surveillance strategies
are needed to determine the distribution and prevalence of differ-
ent lyssavirus species in Africa and Asia. Such strategies must in-
volve the collation of animal disease data and its provision to
public health authorities, to enable them to develop effective pol-
icies (Lembo et al., 2011; Zinsstag et al., 2009). Once surveillance
mechanisms are in place, it is essential to ensure the quality and
reliability of the data and its dissemination within an expert net-
work (Aylan et al., 2011). Importantly, effective surveillance per-
mits early case reporting, which is vital for timely responses and
informed decision-making. The combination of laboratory-based
surveillance, enhanced public awareness and strategic utilization
of potent, inexpensive vaccines is essential for rabies control and
prevention (Murray and Aviso, 2012; Fooks, 2005). Once estab-
lished, an animal surveillance system can be customized and
implemented to support the elimination of both canine and human
rabies (Fooks et al., 2009; Townsend et al., 2012).
Rabies surveillance should include both ‘passive’ and ‘active’
laboratory-based strategies. A ‘passive’ surveillance strategy offers
a continuous monitoring of disease occurrence within a population
by reporting notiﬁable diseases on a case-by-case basis. Passive
surveillance is advantageous because it occurs continuously, and
it requires few resources. In contrast, ‘active’ surveillance is a pro-
Table 1
Comparison of tests currently used in rabies diagnostic testing. Reproduced with permission from (Harkess and Fooks, 2011).
Test Use Unit cost Turn-around time Sensitivity Speciﬁcity
Fluorescent antibody test (FAT) ‘Gold standard’ test Cheap 2–4 h Medium High
Rabies tissue culture infection test (RTCIT) Conﬁrmatory test Moderate 5 days High Medium
Mouse inoculation test (MIT) Conﬁrmatory test Expensive 28 days High Medium
Reverse transcription-polymerase chain reaction (RT-PCR) Screening Cheap 2 days (including RNA extraction) High High
Real-time PCR Screening Cheap 1 day (including RNA extraction) High High
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notiﬁable diseases. While the latter method is more costly and la-
bor intensive, it tends to provide a more complete estimate of dis-
ease frequency. A robust surveillance system should prioritize data
collection, recognising the need for cooperation through a ‘One
Health’ agenda (Fooks, 2007; WHO, 2008; Fisman and Laupland,
2010). An effective system should also be characterized by stan-
dardisation and decentralisation, emphasizing locally-based ef-
forts, and by coordination, interpretation and integration ofFAO
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362 A.C. Banyard et al. / Antiviral Research 98 (2013) 357–364tion system, using a Geographic Information Systems (GIS) linked
to internet-based mapping tools (Rupprecht et al., 2006b). Report-
ing systems, such as the Rabies Bulletin Europe (RBE) (Freuling
et al., 2012) and the OIE World Animal Health Information System
(WAHID) interface, depend on consistent disease reporting, backed
up by conﬁrmatory laboratory diagnosis by participating countries,
both of which are often lacking. Their dependence on different sec-
tors for the development and reporting of case data demonstrates
the need for a multi-sectoral, integrated and inter-disciplinary ap-
proach (Fig. 2). Reliable systematic surveillance of human rabies
deaths and animal prevalence at the national level (Fig. 3) would
markedly improve knowledge and response to rabies, and is ur-
gently needed.8. Conclusions and future perspective
More than 30 years ago, the global eradication of smallpox
demonstrated that well-supported surveillance campaigns areessential to reduce and potentially eliminate an infectious disease
(Fenner et al., 1988). Fortunately, a great deal of progress has been
made against rabies. Animal management, including public educa-
tion, responsible dog ownership and vaccination strategies, have
been identiﬁed as the keystone of modern control programs. Using
this model, the connection between rabies in dogs and humans has
been clearly demonstrated through the successful elimination of
canine rabies from Western Europe and parts of the Americas
(WHO, 2010). Similar campaigns to monitor rabies and vaccination
in dogs in the developing world are receiving international
support. These ‘‘showcase’’ initiatives have demonstrated that it
is possible to eliminate rabies from terrestrial populations.
Information on these initiatives can be obtained from the web
sites of the Rabies Blueprint (http://www.rabiesblueprint.com/)
and World Rabies Day (Briggs and Hanlon, 2007)
(www.worldrabiesday.com).
A number of factors will increase the potential for successful ra-
bies elimination programmes. First, rabies must be made a notiﬁ-
able disease in all countries. Where the necessary infrastructure
A.C. Banyard et al. / Antiviral Research 98 (2013) 357–364 363does not exist, governments must generate facilities for reporting
and surveillance. Veterinary and medical sectors should coordinate
their resources to respond to suspect cases. Importantly, the suc-
cessful establishment of functional reporting systems requires
mechanisms for practical laboratory-based surveillance. The
enhancement of sensible pet care, including vaccination, registra-
tion, routine supervision and population planning, is one of the
most cost-effective elements (Rupprecht et al., 2006a).
Systems must be implemented to accurately monitor the bur-
den of rabies in local areas; those data can then be used to inﬂu-
ence policy, ensuring that resources are allocated in the most
efﬁcient and cost-effective manner. Monitoring relies principally
on reliable, sustained surveillance and reporting; appropriate diag-
nostic capabilities for animal and human cases; and an accurate
epidemiological assessment of the prevalence of rabies in dogs
and humans. This information can drive risk-assessment systems
in local areas, ensure compliance and inﬂuence policy. The conﬁr-
matory diagnosis of all suspect cases is essential for these desired
outcomes (Fig. 3).
Efﬁcient reporting and surveillance systems are essential for
targeted rabies vaccination and elimination strategies. However,
limiting factors including the lack of coordinated initiatives, dog
ecology data and ﬁnancial support for vaccination campaigns all
hamper elimination prospects. However, all of these obstacles
can be overcome through international coordination under the
‘One Health’ initiative (Fooks, 2007), and especially by working col-
lectively within public-private partnerships (Taylor, 2013). Impor-
tantly, the vast majority of domestic dogs are accessible for
vaccination, and educating their owners in the dangers of rabies
will further reduce the burden. However, enhanced local facilities
for surveillance and diagnostics are still essential for control and
elimination initiatives. The implementation of government led
cross-discipline efforts in the establishment of dog vaccination
campaigns are critical in linking the veterinary and medical sectors
as part of the ‘One Health’ initiative to effectively ﬁght rabies.
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